Skip to content

A verification study of the effects of consumption of the test food containing plant extract on male menopause and sexual function in middle-aged men

A verification study of the effects of consumption of the test food containing plant extract on male menopause and sexual function in middle-aged men: a randomized, placebo-controlled, double-blind, parallel-group comparison study - A verification study of the effects of consumption of the test food containing plant extract on male menopause and sexual function in middle-aged men

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
JPRN
Registry ID
JPRN-UMIN000057680
Enrollment
52
Registered
2025-04-22
Start date
2025-04-22
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Healthy Japanese

Interventions

Duration: Four weeks Test product: Sterone power mix HC2 (Hard capsule containing black currant extract, red perilla extract, and inositol mixture) Administration: Take two capsules per day at any t

Sponsors

JAPAN PHARMA Co., Ltd.
Lead Sponsor

Eligibility

Sex/Gender
Male

Inclusion criteria

Inclusion criteria: 1. Japanese 2. Men 3. Individuals aged 45 or more and less than 75 4. Healthy individuals 5. Individuals whose AMS score is between 27 and 49 6. Individuals whose BMI is 23 kg/m2 or more and less than 30 kg/m2 7. Individuals whose blood concentration of total testosterone is 2.5 ng/mL or more at screening 8. Individuals whose blood concentration of free testosterone is 7.5 pg/mL or more at screening

Exclusion criteria

Exclusion criteria: 1. Individuals who are undergoing medical treatment or have a medical history of malignant tumor, heart failure, myocardial infarction, hepatitis B, or hepatitis C 2. Individuals who have a pacemaker or an implantable cardioverter defibrillator (ICD) 3. Individuals who are currently undergoing treatment for any of the following chronic diseases: cardiac arrhythmia, liver disorder, chronic kidney disease, cerebrovascular disorder, rheumatic disease, diabetes mellitus, dyslipidemia, hypertension, or any other chronic diseases 4. Individuals who are taking "Foods for Specified Health Uses" or "Foods with Functional Claims" 5. Individuals who are taking or using medications (including herbal medicines) or supplements 6. Individuals who usually take foods that may affect male menopause and sexual function, such as garlic, L-arginine, zinc, or maca 7. Individuals who are allergic to medicines or foods related to the test product 8. Individuals who have been enrolled in other clinical studies within the last 28 days before the agreement to participate in this study or plan to participate in another study during this study 9. Individuals who have treatment histories of diabetes mellitus, erectile dysfunction, benign prostatic hyperplasia, gastric ulcer, psychosis, dysgeusia, or anemia within last one year 10. Individuals who have mental health issues such as depression disorder, attention deficit/hyperactivity disorder (ADHD), or other issues 11. Individuals who usually drink to excess (average of more than about 20 g/day as absolute alcohol intake) {500 mL: a medium bottle of beer or about 1.5 cans of canned chu-hi, 180 mL: 1 go of sake or about 1.5 glasses of wine, 90 mL: half-go with shochu, 60 mL: a glass of whiskey brandy (double)} 12. Individuals who are judged as ineligible to participate in this study by the physician

Design outcomes

Primary

MeasureTime frame
1. The Aging Males' Symptoms (AMS) at four weeks after intervention (4w)

Secondary

MeasureTime frame
1. The MOS Short-Form 36-Item Health Survey (SF-36) at 4w 2. Total testosterone, free testosterone, luteinizing hormone, and follicle-stimulating hormone at 4w 3. Body weight, body mass index (BMI), body fat percentage, lean body mass, fat mass (whole body, right leg, left leg, right arm, left arm, and trunk), muscle mass (whole body, right leg, left leg, right arm, left arm, and trunk), systolic blood pressure, diastolic blood pressure, waist circumference, total cholesterol (T-Cho), high density lipoprotein-cholesterol (HDL-Cho), low density lipoprotein-cholesterol (LDL-Cho), triglyceride (TG), glucose (GLU), and hemoglobin A1c (HbA1c) at 4w

Countries

Japan

Contacts

Public ContactNaoko Suzuki

ORTHOMEDICO Inc. R&D Department

nao@orthomedico.jp03-3818-0610

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026